Proteinase-Activated receptor 2 modulates OA-related pain, cartilage and bone pathology

Annals of the Rheumatic Diseases

Volumn 75, Issue 11, 2016, Pages 1989-1997

  Huesa, Carmen ^a   Ortiz, Ana C ^a   Dunning, Lynette ^a   McGavin, Laura ^a   Bennett, Louise ^b   McIntosh, Kathryn ^c   Crilly, Anne ^a   Kurowska Stolarska, Mariola ^b   Plevin, Robin ^c   Vant Hof, Rob J ^d   Rowan, Andrew D ^e   McInnes, Iain B ^b   Goodyear, Carl S ^b   Lockhart, John C ^a   Ferrell, William R ^b  

^a UNIVERSITY OF THE WEST OF SCOTLAND   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^d UNIVERSITY OF LIVERPOOL   (United Kingdom)

^e NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Chondrocytes; Inflammation; Osteoarthritis; Synovitis

Indexed keywords

PROTEINASE ACTIVATED RECEPTOR 2;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRALGIA; ARTICLE; BONE DISEASE; CARTILAGE CELL; CARTILAGE DEGENERATION; CONTROLLED STUDY; EXPERIMENTAL OSTEOARTHRITIS; HISTOLOGY; MALE; MICRO-COMPUTED TOMOGRAPHY; MOLECULAR PATHOLOGY; MOUSE; NOCICEPTION; NONHUMAN; OSTEOPHYTE; OSTEOSCLEROSIS; PRIORITY JOURNAL; WEIGHT BEARING; WILD TYPE; ANIMAL; ARTHRITIS, EXPERIMENTAL; ARTICULAR CARTILAGE; BONE; CHONDROCYTE; DISEASE MODEL; HUMAN; METABOLISM; OSTEOARTHRITIS; OSTEOCYTE; PATHOLOGY;

ANIMALS; ARTHRALGIA; ARTHRITIS, EXPERIMENTAL; BONE AND BONES; CARTILAGE, ARTICULAR; CHONDROCYTES; DISEASE MODELS, ANIMAL; HUMANS; MICE; OSTEOARTHRITIS; OSTEOCYTES; RECEPTOR, PAR-2;

EID: 84954287751     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2015-208268     Document Type: Article

References (24)

1. Milner JM, Patel A, Davidson RK, et al. Matriptase is a novel initiator of cartilage matrix degradation in osteoarthritis. Arthritis Rheum 2010;62: 1955-66.
2. Ferrell WR, Lockhart JC, Kelso EB, et al. Essential role for proteinase-Activated receptor-2 in arthritis. J Clin Invest 2003;111:35-41.
3. Kelso EB, Ferrell WR, Lockhart JC, et al. Expression and proinflammatory role of proteinase-Activated receptor 2 in rheumatoid synovium: ex vivo studies using a novel proteinase-Activated receptor 2 antagonist. Arthritis Rheum 2007;56: 765-71.
4. Ferrell WR, Kelso EB, Lockhart JC, et al. Protease-Activated receptor 2: A novel pathogenic pathway in a murine model of osteoarthritis. Ann Rheum Dis 2010;69:2051-4.
5. Amiable N, Martel-Pelletier J, Lussier B, et al. Proteinase-Activated receptor-2 gene disruption limits the effect of osteoarthritis on cartilage in mice: A novel target in joint degradation. J Rheumatol 2011;38:911-20.
6. Jackson MT, Moradi B, Zaki S, et al. Depletion of protease activated receptor (PAR)-2 but not PAR-1 is protective in osteoarthritis through extra-cartilaginous mechanisms. Arthritis Rheumatol 2014;66:3337-48.
7. Glasson SS, Blanchet TJ, Morris EA. The surgical destabilization of the medial meniscus (DMM) model of osteoarthritis in the 129/SvEv mouse. Osteoarthr Cartil 2007;15:1061-9.
8. Zuscik M, Hilton MJ, Zhang X, et al. Regulation of chondrogenesis and chondrocyte differentiation by stress. J Clin Invest 2008;118:429-38.
9. Chia SL, Sawaji Y, Burleigh A, et al. Fibroblast growth factor 2 is an intrinsic chondroprotective agent that suppresses ADAMTS-5 and delays cartilage degradation in murine osteoarthritis. Arthritis Rheum 2009;60:2019-27.
10. Ossovskaya VS, Bunnett NW. Protease-Activated receptors: contribution to physiology and disease. Physiol Rev 2004;84:579-621.
11. Ruan MZ, Dawson B, Jiang MM, et al. Quantitative imaging of murine osteoarthritic cartilage by phase-contrast micro-computed tomography. Arthritis Rheum 2013;65:388-96.
12. Das Neves Borges P, Forte AE, Vincent TL, et al. Rapid, automated imaging of mouse articular cartilage by microCT for early detection of osteoarthritis and finite element modelling of joint mechanics. Osteoarthr Cartil 2014;22:1419-28.
13. Wang Y, Wluka AE, Cicuttini FM. The determinants of change in tibial plateau bone area in osteoarthritic knees: A cohort study. Arthritis Res Ther 2005;7: R687-93.
14. Wang Y, Wluka AE, Davis S, et al. Factors affecting tibial plateau expansion in healthy women over 2.5 years: A longitudinal study. Osteoarthr Cartil 2006;14:1258-64.
15. van der Kraan PM, van den Berg WB. Osteophytes: relevance and biology. Osteoarthr Cartil 2007;15:237-44.
16. ONeill KR, Stutz CM, Mignemi NA, et al. Fracture healing in protease-Activated receptor-2 deficient mice. J Orthop Res 2012;30:1271-6.
17. Goldring SR. Alterations in periarticular bone and cross talk between subchondral bone and articular cartilage in osteoarthritis. Ther Adv Musculoskelet Dis 2012;4:249-58.
18. Roudier M, Li X, Niu QT, et al. Sclerostin is expressed in articular cartilage but loss or inhibition does not affect cartilage remodeling during aging or following mechanical injury. Arthritis Rheum 2013;65:721-31.
19. Vergnolle N, Bunnett NW, Sharkey KA, et al. Proteinase-Activated receptor-2 and hyperalgesia: A novel pain pathway. Nat Med 2001;7:821-6.
20. Helyes Z, Sándor K, Borbély E, et al. Involvement of transient receptor potential vanilloid 1 receptors in protease-Activated receptor-2-induced joint inflammation and nociception. Eur J Pain 2010;14:351-8.
21. Ayral X, Pickering EH, Woodworth TG, et al. Synovitis: A potential predictive factor of structural progression of medial tibiofemoral knee osteoarthritis: results of a 1 year longitudinal arthroscopic study in 422 patients. Osteoarthr Cartil 2005;13:361-7.
22. Roemer FW, Kassim Javaid M, Guermazi A, et al. Anatomical distribution of synovitis in knee osteoarthritis and its association with joint effusion assessed on non-enhanced and contrast-enhanced MRI. Osteoarthr Cartil 2010;18:1269-74.
23. Tindell AG, Kelso EB, Ferrell WR, et al. Correlation of protease-Activated receptor-2 expression and synovitis in rheumatoid and osteoarthritis. Rheumatol Int 2012;32:3077-86.
24. Radin EL, Rose RM. Role of subchondral bone in the initiation and progression of cartilage damage. Clin Orthop Relat Res 1986;213:34-40.